Leticia Oviedo-Serrano
Ciudad Real, CM 13004, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Correction: Spanish version of the short European health literacy survey questionnaire HLS-Q12: Transcultural adaptation and psychometric properties.
Journal: PloS one
Published: October 07, 2025
Evaluating Allium sativum and Vitis vinifera Extracts as Potential Adjuvant Agents in Colorectal Cancer: Insights from HT-29 and Caco-2 Models.
Journal: Biomedicines
Published: July 11, 2025
Correction: Spanish version of the short European Health Literacy Survey Questionnaire HLS-Q12: Transcultural adaptation and psychometric properties.
Journal: PloS one
Published: January 03, 2025
Longitudinal Assessment of Nasopharyngeal Biomarkers Post-COVID-19: Unveiling Persistent Markers and Severity Correlations.
Journal: Journal of proteome research
Published: October 11, 2024
Impact of telenurse-led intervention in clinical trials on health literacy, empowerment, and health outcomes in patients with solid tumours: a pilot quasi-experimental study.
Journal: BMC nursing
Published: July 26, 2023
The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer.
Journal: World journal of surgical oncology
Published: May 30, 2023
Professional competencies of oncology nurses: Recognizing advanced practice in nursing.
Journal: Enfermeria clinica
Published: February 08, 2023
Spanish version of the short European Health Literacy Survey Questionnaire HLS-Q12: Transcultural adaptation and psychometric properties.
Journal: PloS one
Published: December 27, 2022
Clinical features and mortality of COVID-19 patients admitted to ICU according to SOFA score.
Journal: Medicine
Published: July 15, 2022
Pediatric patients with suspected COVID-19 in an emergency department: analysis of characteristics and transmission to contacts.
Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
Published: February 01, 2022
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.
Journal: European journal of clinical investigation
Published: January 28, 2022
Last Updated: 09/26/2026